A detailed history of Schroder Investment Management Group transactions in Zai Lab LTD stock. As of the latest transaction made, Schroder Investment Management Group holds 238,867 shares of ZLAB stock, worth $6.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
238,867
Previous 144,460 65.35%
Holding current value
$6.36 Million
Previous $2.5 Million 130.36%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.25 - $24.14 $1.53 Million - $2.28 Million
94,407 Added 65.35%
238,867 $5.77 Million
Q1 2024

May 14, 2024

BUY
$15.95 - $26.8 $1.04 Million - $1.76 Million
65,502 Added 82.96%
144,460 $2.31 Million
Q4 2023

Feb 13, 2024

BUY
$22.97 - $30.58 $1.81 Million - $2.41 Million
78,958 New
78,958 $2.16 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.61B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.